What does the Introduction convey about the product's identity and research rationale?

• A. The chemical name, all active ingredients, pharmacological class, rationale for research, anticipated indications, and general approach
• B. The trial's recruitment compensation plan
• C. The post-approval marketing plan
• D. The regulatory submissions in each country

Answer: (A)

The Introduction (often called the background) is where the protocol first tells readers what the product is and why the study is being done. It presents the product by its chemical name and lists all active ingredients, describes its pharmacological class, and explains the rationale for the research—why this study is needed and what evidence supports it. It also states the anticipated indications and gives a sense of the general approach of the investigation. This combination helps investigators and ethics committees understand the scientific basis and purpose of the trial.

Elements like recruitment compensation plans, post-approval marketing plans, or regulatory submissions in each country belong to other parts of the protocol or planning documents and do not describe the product’s identity or the research rationale.